Differential effect of weight loss on insulin resistance in surgically treated obese patients

Elza Muscelli, Gertrude Mingrone, Stefania Camastra, Melania Manco, Juliano Alves Pereira, José Carlos Pareja, Ele Ferrannini

Research output: Contribution to journalArticle

110 Citations (Scopus)

Abstract

To compare the effects of equivalent weight loss induced by two bariatric surgical techniques on insulin action in severely obese patients. Eighteen nondiabetic patients with severe obesity (mean [± SD] body mass index: 53.5 ± 9.0 kg/m 2) and 20 sex- and age-matched lean subjects (body mass index: 23.8 ± 3.0 kg/m 2) underwent metabolic studies, including measurement of insulin sensitivity by the insulin clamp technique. Patients then underwent either vertical banded gastroplasty with Roux-en-Y gastric bypass, or biliopancreatic diversion, and were restudied at 5 to 6 months and again at 16 to 24 months postsurgery. At baseline, patients were hyperinsulinemic (194 ± 47 pmol/L vs. 55 ± 25 pmol/L, P <0.0001), hypertriglyceridemic (1.56 ± 0.30 mmol/L vs. 0.78 ± 0.32 mmol/L, P <0.0001), and profoundly insulin resistant (insulin-mediated glucose disposal: 20.8 ± 4.4 μmol/min/kg fat-free mass vs. 52.0 ± 10.1 μmol/min/kg, P <0.0001) as compared with controls. Weight loss by the two procedures was equivalent in both amount (averaging -53 kg) and time course. In the gastric bypass group, insulin sensitivity improved (23.8 ± 6.0 μmol/min/kg at 5 months and 33.7 ± 11.3 μmol/min/kg at 16 months, P <0.01 vs. baseline and controls). In contrast, in the biliopancreatic diversion group, insulin sensitivity was normalized already at 6 months (52.5 ± 12.4 μmol/min/kg, P = 0.72 vs. controls) and increased further at 24 months (68.7 ± 9.5 μmol/min/kg, P <0.01 vs. controls) despite a persistent obese phenotype (body mass index: 33.2 ± 8.0 kg/m 2). In surgically treated obese patients, insulin sensitivity improves in proportion to weight loss with use of predominantly restrictive procedures (gastric bypass), but is reversed completely by predominantly malabsorptive approaches (biliopancreatic diversion) long before normalization of body weight. Selective nutrient absorption and gut hormones may interact with one another in the genesis of the metabolic abnormalities of obesity.

Original languageEnglish
Pages (from-to)51-57
Number of pages7
JournalAmerican Journal of Medicine
Volume118
Issue number1
DOIs
Publication statusPublished - Jan 2005

Fingerprint

Biliopancreatic Diversion
Insulin Resistance
Weight Loss
Gastric Bypass
Insulin
Body Mass Index
Gastroplasty
Bariatrics
Morbid Obesity
Obesity
Fats
Body Weight
Hormones
Phenotype
Glucose
Food

Keywords

  • Biliopancreatic diversion
  • Gastric bypass
  • Insulin resistance
  • Morbid obesity

ASJC Scopus subject areas

  • Nursing(all)

Cite this

Differential effect of weight loss on insulin resistance in surgically treated obese patients. / Muscelli, Elza; Mingrone, Gertrude; Camastra, Stefania; Manco, Melania; Pereira, Juliano Alves; Pareja, José Carlos; Ferrannini, Ele.

In: American Journal of Medicine, Vol. 118, No. 1, 01.2005, p. 51-57.

Research output: Contribution to journalArticle

Muscelli, E, Mingrone, G, Camastra, S, Manco, M, Pereira, JA, Pareja, JC & Ferrannini, E 2005, 'Differential effect of weight loss on insulin resistance in surgically treated obese patients', American Journal of Medicine, vol. 118, no. 1, pp. 51-57. https://doi.org/10.1016/j.amjmed.2004.08.017
Muscelli, Elza ; Mingrone, Gertrude ; Camastra, Stefania ; Manco, Melania ; Pereira, Juliano Alves ; Pareja, José Carlos ; Ferrannini, Ele. / Differential effect of weight loss on insulin resistance in surgically treated obese patients. In: American Journal of Medicine. 2005 ; Vol. 118, No. 1. pp. 51-57.
@article{4dd369006fb64fbfadb0f79985816b42,
title = "Differential effect of weight loss on insulin resistance in surgically treated obese patients",
abstract = "To compare the effects of equivalent weight loss induced by two bariatric surgical techniques on insulin action in severely obese patients. Eighteen nondiabetic patients with severe obesity (mean [± SD] body mass index: 53.5 ± 9.0 kg/m 2) and 20 sex- and age-matched lean subjects (body mass index: 23.8 ± 3.0 kg/m 2) underwent metabolic studies, including measurement of insulin sensitivity by the insulin clamp technique. Patients then underwent either vertical banded gastroplasty with Roux-en-Y gastric bypass, or biliopancreatic diversion, and were restudied at 5 to 6 months and again at 16 to 24 months postsurgery. At baseline, patients were hyperinsulinemic (194 ± 47 pmol/L vs. 55 ± 25 pmol/L, P <0.0001), hypertriglyceridemic (1.56 ± 0.30 mmol/L vs. 0.78 ± 0.32 mmol/L, P <0.0001), and profoundly insulin resistant (insulin-mediated glucose disposal: 20.8 ± 4.4 μmol/min/kg fat-free mass vs. 52.0 ± 10.1 μmol/min/kg, P <0.0001) as compared with controls. Weight loss by the two procedures was equivalent in both amount (averaging -53 kg) and time course. In the gastric bypass group, insulin sensitivity improved (23.8 ± 6.0 μmol/min/kg at 5 months and 33.7 ± 11.3 μmol/min/kg at 16 months, P <0.01 vs. baseline and controls). In contrast, in the biliopancreatic diversion group, insulin sensitivity was normalized already at 6 months (52.5 ± 12.4 μmol/min/kg, P = 0.72 vs. controls) and increased further at 24 months (68.7 ± 9.5 μmol/min/kg, P <0.01 vs. controls) despite a persistent obese phenotype (body mass index: 33.2 ± 8.0 kg/m 2). In surgically treated obese patients, insulin sensitivity improves in proportion to weight loss with use of predominantly restrictive procedures (gastric bypass), but is reversed completely by predominantly malabsorptive approaches (biliopancreatic diversion) long before normalization of body weight. Selective nutrient absorption and gut hormones may interact with one another in the genesis of the metabolic abnormalities of obesity.",
keywords = "Biliopancreatic diversion, Gastric bypass, Insulin resistance, Morbid obesity",
author = "Elza Muscelli and Gertrude Mingrone and Stefania Camastra and Melania Manco and Pereira, {Juliano Alves} and Pareja, {Jos{\'e} Carlos} and Ele Ferrannini",
year = "2005",
month = "1",
doi = "10.1016/j.amjmed.2004.08.017",
language = "English",
volume = "118",
pages = "51--57",
journal = "American Journal of Medicine",
issn = "0002-9343",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Differential effect of weight loss on insulin resistance in surgically treated obese patients

AU - Muscelli, Elza

AU - Mingrone, Gertrude

AU - Camastra, Stefania

AU - Manco, Melania

AU - Pereira, Juliano Alves

AU - Pareja, José Carlos

AU - Ferrannini, Ele

PY - 2005/1

Y1 - 2005/1

N2 - To compare the effects of equivalent weight loss induced by two bariatric surgical techniques on insulin action in severely obese patients. Eighteen nondiabetic patients with severe obesity (mean [± SD] body mass index: 53.5 ± 9.0 kg/m 2) and 20 sex- and age-matched lean subjects (body mass index: 23.8 ± 3.0 kg/m 2) underwent metabolic studies, including measurement of insulin sensitivity by the insulin clamp technique. Patients then underwent either vertical banded gastroplasty with Roux-en-Y gastric bypass, or biliopancreatic diversion, and were restudied at 5 to 6 months and again at 16 to 24 months postsurgery. At baseline, patients were hyperinsulinemic (194 ± 47 pmol/L vs. 55 ± 25 pmol/L, P <0.0001), hypertriglyceridemic (1.56 ± 0.30 mmol/L vs. 0.78 ± 0.32 mmol/L, P <0.0001), and profoundly insulin resistant (insulin-mediated glucose disposal: 20.8 ± 4.4 μmol/min/kg fat-free mass vs. 52.0 ± 10.1 μmol/min/kg, P <0.0001) as compared with controls. Weight loss by the two procedures was equivalent in both amount (averaging -53 kg) and time course. In the gastric bypass group, insulin sensitivity improved (23.8 ± 6.0 μmol/min/kg at 5 months and 33.7 ± 11.3 μmol/min/kg at 16 months, P <0.01 vs. baseline and controls). In contrast, in the biliopancreatic diversion group, insulin sensitivity was normalized already at 6 months (52.5 ± 12.4 μmol/min/kg, P = 0.72 vs. controls) and increased further at 24 months (68.7 ± 9.5 μmol/min/kg, P <0.01 vs. controls) despite a persistent obese phenotype (body mass index: 33.2 ± 8.0 kg/m 2). In surgically treated obese patients, insulin sensitivity improves in proportion to weight loss with use of predominantly restrictive procedures (gastric bypass), but is reversed completely by predominantly malabsorptive approaches (biliopancreatic diversion) long before normalization of body weight. Selective nutrient absorption and gut hormones may interact with one another in the genesis of the metabolic abnormalities of obesity.

AB - To compare the effects of equivalent weight loss induced by two bariatric surgical techniques on insulin action in severely obese patients. Eighteen nondiabetic patients with severe obesity (mean [± SD] body mass index: 53.5 ± 9.0 kg/m 2) and 20 sex- and age-matched lean subjects (body mass index: 23.8 ± 3.0 kg/m 2) underwent metabolic studies, including measurement of insulin sensitivity by the insulin clamp technique. Patients then underwent either vertical banded gastroplasty with Roux-en-Y gastric bypass, or biliopancreatic diversion, and were restudied at 5 to 6 months and again at 16 to 24 months postsurgery. At baseline, patients were hyperinsulinemic (194 ± 47 pmol/L vs. 55 ± 25 pmol/L, P <0.0001), hypertriglyceridemic (1.56 ± 0.30 mmol/L vs. 0.78 ± 0.32 mmol/L, P <0.0001), and profoundly insulin resistant (insulin-mediated glucose disposal: 20.8 ± 4.4 μmol/min/kg fat-free mass vs. 52.0 ± 10.1 μmol/min/kg, P <0.0001) as compared with controls. Weight loss by the two procedures was equivalent in both amount (averaging -53 kg) and time course. In the gastric bypass group, insulin sensitivity improved (23.8 ± 6.0 μmol/min/kg at 5 months and 33.7 ± 11.3 μmol/min/kg at 16 months, P <0.01 vs. baseline and controls). In contrast, in the biliopancreatic diversion group, insulin sensitivity was normalized already at 6 months (52.5 ± 12.4 μmol/min/kg, P = 0.72 vs. controls) and increased further at 24 months (68.7 ± 9.5 μmol/min/kg, P <0.01 vs. controls) despite a persistent obese phenotype (body mass index: 33.2 ± 8.0 kg/m 2). In surgically treated obese patients, insulin sensitivity improves in proportion to weight loss with use of predominantly restrictive procedures (gastric bypass), but is reversed completely by predominantly malabsorptive approaches (biliopancreatic diversion) long before normalization of body weight. Selective nutrient absorption and gut hormones may interact with one another in the genesis of the metabolic abnormalities of obesity.

KW - Biliopancreatic diversion

KW - Gastric bypass

KW - Insulin resistance

KW - Morbid obesity

UR - http://www.scopus.com/inward/record.url?scp=11444261322&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=11444261322&partnerID=8YFLogxK

U2 - 10.1016/j.amjmed.2004.08.017

DO - 10.1016/j.amjmed.2004.08.017

M3 - Article

C2 - 15639210

AN - SCOPUS:11444261322

VL - 118

SP - 51

EP - 57

JO - American Journal of Medicine

JF - American Journal of Medicine

SN - 0002-9343

IS - 1

ER -